HHC-P (hexahydrocannabiphorol) is a semi-synthetic cannabinoid created by hydrogenating THCP, a rare but naturally occurring compound in cannabis. It belongs to the same chemical family as HHC but carries a longer side chain that makes it more potent. HHC-P has gained attention in the hemp-derived cannabinoid market as one of the strongest legal alternatives to THC, though its regulatory status is shifting rapidly across the United States.
How HHC-P Relates to HHC and THCP
To understand HHC-P, it helps to know its two parent compounds. HHC (hexahydrocannabinol) is a hydrogenated form of THC with a five-carbon side chain. THCP (tetrahydrocannabiphorol) is a naturally occurring cannabinoid with a seven-carbon side chain, which gives it significantly stronger binding to cannabinoid receptors in the brain. HHC-P is essentially the intersection of these two: it has HHC’s hydrogenated core structure combined with THCP’s longer seven-carbon chain.
The molecular formula of HHC-P is C₂₃H₃₆O₂, compared to HHC’s C₂₁H₃₂O₂. That two-carbon difference in the side chain is the key distinction. Both compounds are classified as tricyclic terpenoid derivatives, but the longer chain on HHC-P increases its ability to interact with CB1 receptors, the same receptors THC activates to produce a high. While both HHC and HHC-P exist in trace amounts in the cannabis plant, the quantities are far too small for commercial extraction, so virtually all HHC-P on the market is manufactured in a lab.
How HHC-P Is Made
Despite what some vendors claim, HHC-P almost certainly isn’t made directly from CBD. Converting CBD to HHC-P would require adding two extra carbons to the side chain, a complex chemical step called homologation that doesn’t work easily on a chain without reactive functional groups. Researchers have noted this claim is unlikely given the chemistry involved.
The more plausible route starts with THCP. Manufacturers either synthesize THCP from other precursors or isolate it from cannabis strains bred to produce higher THCP levels. They then hydrogenate THCP, a process that adds hydrogen atoms to the molecule’s double bond, converting it into HHC-P. This is the same type of reaction used to turn vegetable oil into margarine. The hydrogenation step also saturates the cyclohexyl ring, which makes the molecule more chemically stable than its THC-based counterpart.
One complication of this synthesis is the formation of byproducts. Researchers have isolated and characterized several intermediates and side products in HHC-P production, including iso-HHCP, which can form when the starting material cyclizes in an alternate pattern before hydrogenation. The presence of these impurities is one reason product quality varies widely between manufacturers.
Effects and Potency
No published human clinical trials have measured HHC-P’s effects in a controlled setting. Most of what’s known comes from animal studies on HHC (its close structural relative) and from user reports. In rat studies, HHC crosses the blood-brain barrier readily and produces behavioral effects similar to THC: reduced movement, increased anxiety-like behavior, and impaired sensorimotor gating at higher doses (10 mg/kg). HHC-P, with its longer side chain, is widely reported by users to be substantially stronger than standard HHC.
For HHC specifically, blood concentrations peak about 30 minutes after smoking, with the compound detectable in blood and oral fluid for at least three hours. The half-life in blood is roughly 1.3 to 1.6 hours for the two forms (epimers) of HHC. HHC-P’s longer side chain means the body metabolizes it somewhat differently. It undergoes more extensive breakdown along that seven-carbon chain, which could contribute to the longer-lasting effects users commonly describe. However, precise onset and duration data for HHC-P in humans hasn’t been published.
Users typically report that HHC-P produces a strong, sedating high with pronounced body effects. Because no standardized dosing guidelines exist, the range of experiences varies enormously depending on the product, the dose, and individual tolerance.
Drug Testing
One detail that surprises many people: HHC-P may not trigger a positive result on standard THC drug tests. In a study where a THC-abstinent volunteer consumed a single 4 mg oral dose of HHC-P, urine immunoassays designed to detect THC metabolites came back negative. This is because the antibodies used in standard drug panels are tuned to recognize THC-specific metabolites, and HHC-P’s metabolites are structurally different enough to avoid cross-reactivity.
That said, this was a single-dose finding in one individual. Chronic or high-dose use hasn’t been studied, and some HHC-P products contain blends with delta-8 THC or other cannabinoids that would absolutely show up on a drug test. Researchers have recommended that labs begin including HHC-P metabolites in their routine screening methods, so this gap may not last.
Available Product Types
HHC-P is sold in several forms, almost always blended with other cannabinoids rather than used on its own. Vape cartridges are among the most common, typically combining HHC-P distillate with delta-8 THC and terpenes. Disposable vapes follow the same formula in a single-use device. Tinctures usually pair HHC-P distillate with a carrier oil and delta-8, with bottles commonly containing around 1,000 mg of distillate. Pure HHC-P distillate is also available in small quantities, typically 0.5 to 5 grams, for people who want to mix their own products. Edibles with HHC-P come in doses ranging from around 10 mg to 50 mg per serving.
Because HHC-P is stronger than many other hemp-derived cannabinoids, starting doses in commercial products tend to be lower than what you’d see for delta-8 THC or even standard HHC. The blending with milder cannabinoids is partly a way to moderate the intensity.
Safety Concerns
The honest answer on safety is that very little is known. No long-term human studies exist for HHC-P. The closest data comes from acute toxicity testing of HHC in rats, where it was classified as a Category 4 substance under international guidelines, meaning it has relatively mild acute toxicity with an estimated lethal dose of 1,000 mg/kg. For context, Category 4 is the lowest toxicity classification that still warrants a hazard label.
The bigger safety concern isn’t the cannabinoid itself but the manufacturing process. Hydrogenation and cyclization reactions can produce unintended byproducts, and the hemp-derived cannabinoid market has minimal quality control requirements in most states. Without third-party lab testing that specifically screens for synthesis impurities (not just cannabinoid potency), consumers have limited ways to verify what’s actually in a product.
Legal Status
HHC-P occupies a legal gray area at the federal level. The 2018 Farm Bill legalized hemp and its derivatives as long as they contain less than 0.3% delta-9 THC by dry weight. Because HHC-P is technically derived from hemp-sourced cannabinoids and isn’t delta-9 THC, some manufacturers argue it’s federally legal. Federal agencies haven’t issued a definitive ruling specifically naming HHC-P.
At the state level, the picture is much clearer, and it’s increasingly restrictive. A growing number of states have moved to ban or heavily regulate semi-synthetic cannabinoids, and these laws generally sweep in HHC-P along with HHC, THCP, and THC-O. As of 2025, states with outright bans or severe restrictions on synthetic and semi-synthetic cannabinoids include Alaska, California, Colorado, Delaware, Hawaii, Idaho, Mississippi, Montana, Nevada, New Mexico, New York, North Dakota, Oregon, Rhode Island, Texas, Utah, Vermont, Washington, and West Virginia. Texas specifically prohibits any hemp product containing a detectable amount of a cannabinoid not naturally occurring in intact hemp. Utah bans all chemically converted or synthesized cannabinoids.
A second tier of states, including Iowa, Kansas, Louisiana, Michigan, Minnesota, New Hampshire, and Virginia, restrict cannabinoids through total THC thresholds per serving or package, with catch-all provisions that can capture analogs like HHC-P. The regulatory landscape is shifting quickly, with multiple states adding new restrictions each year. If you’re in a state not listed here, that doesn’t guarantee HHC-P is legal there; it may simply mean the state hasn’t addressed it yet.